Over 280 million people (3% of the world) live with chronic hepatitis B and C, WHO says in new 2026 Global Hepatitis Report.
Over 280 million people, approximately 3% of the global population, were living with chronic hepatitis B and C as of 2024, according to the new WHO 2026 Global Hepatitis Report.
What happened
Over 280 million people, approximately 3% of the global population, were living with chronic hepatitis B and C as of 2024, according to the new WHO 2026 Global Hepatitis Report.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Hubs
Briefings
More story pages
Bristol Myers' $14 billion schizophrenia drug is not working out, Bloomberg reports. The acquisition aimed to transform treatment for the mental health condition.
Bristol Myers Squibb's $14 billion acquisition of a neuroscience drug intended to revolutionize schizophrenia treatment is not progressing as hoped, Bloomberg reports.
FDA proposes to withdraw Amgen drug for rare autoimmune diseases over effectiveness concerns.
The FDA is proposing to withdraw Amgen's drug for rare autoimmune diseases due to effectiveness concerns.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.